OncoSec Medical Inc (ONCSQ)

[Titan V]

Thanks for sharing Guti.

I expect the melanoma Keytruda combo data to be released at the Society for Melanoma Research Congress 2016, Nov 6-9.
http://www.melanomacongress.com

In case you missed it, they will be presenting at the Biomarkers & Precision Medicine USA Congress 2016.
http://www.biomarkersusa-congress.com/2016-speaker-line-up/

Biomarkers and Precision Medicine USA Congress Day 2 – 4th October 2016

14.00 – 14.30
Biomarker Development for Intratumoral Gene Therapy with DNA-encoded IL-12
Patient selection biomarkers for low TIL/low anti-PD1 responder population
Pharmacodynamic (PD) biomarkers of effective in-situ vaccination
Robert Pierce, Chief Scientific Strategist, OncoSec Medical

15.30 – 16.00
Panel Discussion- Immuno-oncology Biomarker Development
Challenges in Precision medicine
Status of PDL1 assay and biomarker development and other pathways
Non Respondence of PDL1
Lessons learnt
Chair: Adil Daud, Professor of Medicine, University of California, San Francisco
Panellists:
Robert Pierce, Chief Scientific Strategist, OncoSec Medical, Chan Whiting, Associate Director, Aduro Biotech

16.00 – 16.30
Biomarker Strategy To Guide Clinical Development Of Cancer Immunotherapy
- Review novel Biomarkers
- Discuss clinical and Biomarkers correlations
- Mutation burden and response
Adil Daud, Professor of Medicine, University of California, San Francisco

http://www.biomarkersusa-congress.com/wordpress/wp-content/uploads/2016/09/BF-Biomarkers-and-Precision-Medicine-USA-090916.pdf

It's going to be an exciting Q4!